MK-0893

DB12044InvestigationalSmall molecule

MK0893 has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Diabetes Mellitus, Type 2.

Chemical structure of MK-0893
Mechanism
Curator reviewed
Formula / weight
C32H27Cl2N3O4 · 588.49 g/mol (avg)
Code names
MK-0893

Resolves to

Compound
UNIICCP2U6LWTPChEMBLCHEMBL1933349PubChem11570626
Structure
InChIKeyDNTVJEMGHBIUMW-IBGZPJMESA-NSMILESCOC1=CC2=CC=C(C=C2C=C1)C1=CC(=NN1[C@@H](C)C1=CC=C(C=C1)C(=O)NCCC(O)=O)C1=CC(Cl)=CC(Cl)=C1
Targets
P47871GCGR

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with MK-0893, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In